Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Doxycycline 40 mg vs placebo HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg vs placebo Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg vs placebo Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Azithromycin vs doxycycline 100 mg HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Azithromycin vs doxycycline 100 mg Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Azithromycin vs doxycycline 100 mg Assessment of erythema or telangiectasia ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Azithromycin vs doxycycline 100 mg Time needed until improvement of the skin lesions ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Azelaic acid vs placebo HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg + azelaic acid gel vs doxycycline 40 mg + metronidazole gel HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
'As required' medication vs regular timed medication Mental state: important change in mental state · seriously mentally ill people in hospital 'As required' medication regimens for seriously mentally ill people in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
'As required' medication vs regular timed medication Behaviour: important change in behaviour · seriously mentally ill people in hospital 'As required' medication regimens for seriously mentally ill people in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
'As required' medication vs regular timed medication Behaviour: aggression · seriously mentally ill people in hospital 'As required' medication regimens for seriously mentally ill people in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
'As required' medication vs regular timed medication Dosage: important difference in dose used · seriously mentally ill people in hospital 'As required' medication regimens for seriously mentally ill people in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
'As required' medication vs regular timed medication Adverse events: important adverse events · seriously mentally ill people in hospital 'As required' medication regimens for seriously mentally ill people in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
'As required' medication vs regular timed medication Satisfaction with care: important change in satisfaction with care · seriously mentally ill people in hospital 'As required' medication regimens for seriously mentally ill people in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
'As required' medication vs regular timed medication Cost: important change in cost · seriously mentally ill people in hospital 'As required' medication regimens for seriously mentally ill people in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
PERPHENAZINE vs ANY ANTIPSYCHOTICS Death ‐ not reported · patients with schizophrenia Perphenazine for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PERPHENAZINE vs ANY ANTIPSYCHOTICS Economic outcomes ‐ not reported · patients with schizophrenia Perphenazine for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PERPHENAZINE vs ANY ANTIPSYCHOTICS Service use and hospitalisation: admission ‐ not reported · patients with schizophrenia Perphenazine for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PERPHENAZINE vs PLACEBO Adverse events: death ‐ not reported · patients with schizophrenia Perphenazine for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PERPHENAZINE vs PLACEBO Adverse events: serious adverse events ‐ not reported · patients with schizophrenia Perphenazine for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PERPHENAZINE vs PLACEBO Economic outcomes ‐ not reported · patients with schizophrenia Perphenazine for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PERPHENAZINE vs PLACEBO Service use and hospitalisation: admission ‐ not reported · patients with schizophrenia Perphenazine for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
Weight loss vs control Cure rates by patient observation (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Soy‐rich diet vs control Condition‐specific quality of life ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Soy‐rich diet vs control Adverse effects ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Soy‐rich diet vs control Cure rates by symptom quantification (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Soy‐rich diet vs control Improvement rates by symptom quantification (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Soy‐rich diet vs control Incontinent episodes per week (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Decreasing fluids vs increasing fluids Cure rates by patient observation (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Decreasing fluids vs increasing fluids Improvement rates by patient observation (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Decreasing fluids vs increasing fluids Cure rates by symptom quantification (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Decreasing fluids vs increasing fluids Improvement rates by symptom quantification (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Caffeine reduction vs control Cure rates by patient observation (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Caffeine reduction vs control Improvement rates by patient observation (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Caffeine reduction vs control Adverse effects ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Caffeine reduction vs control Cure rates by symptom quantification (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Caffeine reduction vs control Improvement rates by symptom quantification (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Lifestyle weight loss vs metformin weight loss Cure rates by patient observation (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Lifestyle weight loss vs metformin weight loss Improvement rates by patient observation (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Lifestyle weight loss vs metformin weight loss Condition‐specific quality of life ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Lifestyle weight loss vs metformin weight loss Adverse effects ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Lifestyle weight loss vs metformin weight loss Cure rates by symptom quantification (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Lifestyle weight loss vs metformin weight loss Improvement rates by symptom quantification (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Soy‐rich diet vs control Cure rates by patient observation (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Soy‐rich diet vs control Improvement rates by patient observation (all UI types) ‐ not reported · adults with urinary incontinence Lifestyle interventions for the treatment of urinary incontinence in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs antipsychotics Kidney dysfunction outcome not available in any study · participants with schizophrenia Lithium for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |